Vadimezan is a tumor-vascular disrupting agent from the xanthenone class that functions by attacking the blood supply of cancerous tumors to induce regression. This compound is primarily investigated for… Read more
Vadimezan is a tumor-vascular disrupting agent from the xanthenone class that functions by attacking the blood supply of cancerous tumors to induce regression. This compound is primarily investigated for the treatment of solid tumors in various clinical settings. To ensure the integrity of pharmaceutical research, laboratories utilize high-quality reference standards of Vadimezan API alongside its related impurities and stable isotope labelled compounds. These materials are essential for accurate impurity profiling, method validation, and rigorous quality control testing during pharmaceutical development. By providing chemically characterized standards for both pharmacopeial and non-pharmacopeial impurities, these analytical tools support the precise quantification and identification of degradation products or synthetic by-products. Utilizing these specialized reference materials enables researchers to meet stringent regulatory requirements and maintain consistent analytical performance throughout the lifecycle of drug analysis.